RxDoctor Payments Data

Hong Tieu, MD

Infectious Disease · New York, NYNPI 1538383013

Payments from drug & device makers

What this record shows

That places this record below the midpoint for infectious disease clinicians in NY, where the typical reported total is $190.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$176,962in research payments, 2019–2025

Across 16 payments — averaging $11,060 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$169K
  • Pfizer$8K

How this compares

$0 in reported general payments places this provider in the 15th percentile of 799 infectious disease providers in New York.

See all infectious disease providers in New York →

Medicare billing

Part B allowed, 2024
$4,863
Medicare patients
13
Services billed
39

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala12$44,908
IsentressRaltegravir Potassium11$19,426
Fluticasone Propionate15$95

Paid to pharmacies, not to this prescriber.

Other infectious disease in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →